Lumida
/ITCI
⌘K
Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc

ITCI
$131.87USD-0.04%-0.05 today

MARKET CAP

14.0B

P/E (TTM)

FWD P/E

DAY RANGE

$132 – $132

52W RANGE

$64
$132
STATEMENT·Income statement
USD · GAAP
METRICFY 2020FY 2021FY 2022FY 2023FY 2024TREND
Sales, Adj.$22.8M$83.8M$250.3M$464.4M$680.9M
YoY %+37537.1%+267.3%+198.7%+85.5%+46.6%
P / Sales
EV / Sales
Gross Profit, Adj.$20.9M$75.8M$229.9M$430.6M$623.9M
YoY %+34410.7%+262.2%+203.4%+87.3%+44.9%
Margin %91.7%90.4%91.8%92.7%91.6%
EV / Gross Profit
EBITDA, Adj.$-230.7M$-285.2M$-263.0M$-158.9M$-116.2M
YoY %-50.3%-23.6%+7.8%+39.6%+26.8%
Margin %-1011.3%-340.3%-105.1%-34.2%-17.1%
EV / EBITDA
EBIT$-231.2M$-285.7M$-263.6M$-159.4M$-116.7M
YoY %-50.1%-23.6%+7.7%+39.5%+26.8%
Margin %-1013.6%-340.9%-105.3%-34.3%-17.1%
EV / EBIT
Net Income$-227.0M$-284.1M$-256.3M$-139.7M$-74.7M
YoY %-53.7%-25.2%+9.8%+45.5%+46.5%
Net Margin-995.1%-339.0%-102.4%-30.1%-11.0%
EPS (GAAP)-$3.23-$3.50-$2.72-$1.46-$0.72
YoY %-20.5%-8.4%+22.3%+46.3%+50.7%